Earth Science Tech, Inc. (ETST) Developing Products for Healthy Changes in the Lives of Individuals

November 9, 2018 09:55:37
  • Offering women affordable, discreet and anonymous testing for sexually transmitted infections
  • Formulating a full spectrum CBD beverage focused on immunity with possible benefits to cancer treatment
  • Providing a unique product line for optimal relaxation, enhanced focus and assistance with nicotine reduction therapy

Earth Science Tech, Inc. (OTCQB: ETST) is a biotech company developing and marketing health-oriented CBD products and continually expanding its product line to positively change individual lives. The company is doing this through the creation of products like its Hygee medical devices, a CBD beverage and KannaBidoiD products.

Hygee medical devices provide women access to cost-effective testing while protecting their privacy. This self-sampling kit allows woman to discreetly test for sexually transmitted infections (STIs). Similar to a feminine hygiene panty liner, the device is worn for four hours to collect a cervical cell sample. Once collected, the sample is then mailed to the Procrea Fertility lab where it is tested for STIs. This is a positive step forward for women who lack easy access to health care and desire an anonymous, discreet means of testing. The device has already been proven successful in detecting chlamydia and is being tested for similar results for gonorrhea. In the near future, testing will be added for additional STIs and non-STI infections.

ETST has started formulating a full spectrum CBD beverage focused on immunity. The company is utilizing its University of Central Oklahoma Provisional Patent with the help of Dr. Aube, his advisory team and current manufacturing operations near its headquarters (

A study conducted by the University in 2015 found that ETST’s hemp oil solution, used in appropriate CBD concentrations, had the ability to stimulate important immune cells called macrophages.  According to a press release from January 26, 2015 (, lead investigator Dr. Wei R. Chen and his team believed that “the effects of hemp oil enriched with CBD on immune cells may be used to improve cancer treatment, particularly in combination with other treatment modalities.”

ETST has a unique product line called KannaBidoiD (KBD). KBD is a formulation of Kanna and CBD that is distributed in CBD infused edibles and vape products. Kanna is believed to decrease anxiety and, when combined with ETST’s CBD, provides optimal relaxation and enhanced focus while assisting with nicotine reduction therapy.

ETST offers the highest purity and quality, full-spectrum, high-grade cannabinoids on the market. It aims to bring to market therapies for the treatment of certain targeted medical conditions, putting individuals’ health back into their own hands.

For more information, visit the company’s website at

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office